- COMPOUNDS AS GLP-1R AGONISTS
-
The present application provides compounds that may be used as a glucagon-like peptide-1 receptors (GLP-1R) agonist, or stereoisomers, tautomers, or pharmaceutically acceptable salts of any of the foregoing. Also provided are pharmaceutical compositions containing such compounds, or stereoisomers, tautomers, or pharmaceutically acceptable salts of any of the foregoing. Methods of prepare these compounds and compositions and method of using them to treat or present a disease or a condition mediated by GLP-1R.
- -
-
Paragraph 0379-0380
(2022/03/07)
-
- COMPOUNDS FOR THE TREATMENT OF HIV
-
The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula (I), processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.
- -
-
Page/Page column 255
(2013/03/26)
-
- NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT
-
The present invention encompasses compounds of Formula (I) as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and methods of use are also
- -
-
Page/Page column 23; 29
(2008/12/05)
-
- Indazole compounds, and their production and use
-
A compound of the formula: STR1 wherein R is a C1 -C5 alkyl group, a C3 -C4 alkenyl group, a C3 -C4 alkynyl group or a C1 -C3 alkoxy(C1 -C2)alkyl
- -
-
-
- Synthesis of 1-Substituted 3-(Dialkylaminoalkoxy)-4,5,6,7-tetrahydro-1H-indazoles
-
4,5,6,7-Tetrahydro-3-indazolone was prepared by catalytic hydrogenation of 3-indazolone, and its reaction with dialkylaminoalkyl chloride was studied.In addition, a number of 1-substituted 3-(dialkylaminoalkoxy)-4,5,6,7-tetrahydro-1H-indazoles were prepar
- Soga, Takeo,Niwa, Hirosuke,Shiraishi, Takanori
-
p. 825 - 826
(2007/10/02)
-